Dynamics of clinical and biological indices of the asthenic symptom-complex during immunotropic therapy of patients with schizophrenia
Authors:
- T. P. KlyushnikTKT. P. Klyushnik
- А. В. ЯкимецАЯА. В. Якимец
- 1 January 2018
- journal article
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 118 (3) , 70-76
Abstract
LE and a1-PI reflect the clinical and biological features of the asthenic symptom-complex which develops within the endogenous process. Normal/reduced activity of LE accompanied by the increased activity of a1-PI is the best predictor of bestim efficacy in terms of reduction of asthenic symptoms.Keywords
This publication has 16 references indexed in Scilit:
- Biomarkers in schizophrenia: A focus on blood based diagnostics and theranosticsWorld Journal of Psychiatry, 2016
- A Psychometric Study of the Multidimensional Fatigue Inventory to Assess Fatigue in Patients with Schizophrenia Spectrum DisordersCommunity Mental Health Journal, 2014
- Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatmentEuropean Neuropsychopharmacology, 2014
- Autoimmunity, Inflammation, and Psychosis: A Search for Peripheral MarkersBiological Psychiatry, 2014
- Inflammatory markers in schizophrenia in agedS.S. Korsakov Journal of Neurology and Psychiatry, 2014
- Sleep, Fatigue, and Functional Health in Psychotic PatientsSchizophrenia Research and Treatment, 2013
- The Question of Pro-Inflammatory Immune Activity in Schizophrenia and the Potential Importance of Anti-Inflammatory Drugs2013
- Management of the Negative Symptoms of SchizophreniaCNS Drugs, 2003
- Therapie subklinischer (subdiagnostischer) Syndrome des SchizophreniespektrumsFortschritte der Neurologie · Psychiatrie, 2001
- Assessing the Efficacy of Treatments for the Deficit Syndrome of SchizophreniaNeuropsychopharmacology, 2000